Core Insights - The company, Xinda Co., Ltd. (603086), reported a revenue of 586 million yuan for Q3 2025, representing a year-on-year decline of 5.59% [1] - The net profit for Q3 was 59.84 million yuan, showing a significant year-on-year increase of 5447.46% [1] - For the first three quarters, the net profit reached 196 million yuan, marking a year-on-year growth of 3064.56% [1] - The primary driver for the profit increase was the substantial rise in market prices of the main product, Acetochlor, and the successful sales of the newly developed product series, Pyrazolyl Quinclorac [1] Financial Performance - Q3 revenue: 586 million yuan, down 5.59% year-on-year [1] - Q3 net profit: 59.84 million yuan, up 5447.46% year-on-year [1] - Net profit for the first three quarters: 196 million yuan, up 3064.56% year-on-year [1] Product Performance - Main product: Acetochlor, experienced a significant price increase [1] - New product series: Pyrazolyl Quinclorac achieved sales in the current year, contributing to gross profit growth [1]
先达股份:第三季度净利润为5984.91万元,同比增长5447.46%